Clinical Significance of Survivin Expression in Patients with Urothelial Carcinoma
暂无分享,去创建一个
[1] Aaas News,et al. Book Reviews , 1893, Buffalo Medical and Surgical Journal.
[2] Hong-yan Cheng,et al. Association between survivin -31G>C polymorphism and cancer risk: meta-analysis of 29 studies , 2014, Journal of Cancer Research and Clinical Oncology.
[3] C. Kwak,et al. Prognostic Role of Survivin in Bladder Cancer: A Systematic Review and Meta-Analysis , 2013, PloS one.
[4] Zhi-hui Yang,et al. Polymorphisms of survivin and its protein expression are associated with colorectal cancer susceptibility in Chinese population. , 2013, DNA and cell biology.
[5] P. Singh,et al. Diagnostic role of survivin in urinary bladder cancer. , 2013, Asian Pacific journal of cancer prevention : APJCP.
[6] Cheng-ling Zhao,et al. Expression of survivin and patients survival in non-small cell lung cancer: a meta-analysis of the published studies , 2012, Molecular Biology Reports.
[7] S. Fulda,et al. Survivin as a prognostic/predictive marker and molecular target in cancer therapy. , 2012, Current medicinal chemistry.
[8] Yongmei Yin,et al. Association between survivin −31G>C promoter polymorphism and cancer risk: a meta-analysis , 2012, European Journal of Human Genetics.
[9] W. Marsden. I and J , 2012 .
[10] N. Sato,et al. Nuclear, but not cytoplasmic, localization of survivin as a negative prognostic factor for survival in upper urinary tract urothelial carcinoma , 2012, Virchows Archiv.
[11] B. Mittal,et al. Survivin promoter −31G/C (rs9904341) polymorphism and cancer susceptibility: a meta-analysis , 2011, Molecular Biology Reports.
[12] .. AsociaciónAmericanadeUrología. [Non-muscle invasive bladder cancer]. , 2011, Archivos espanoles de urologia.
[13] M. Ringnér,et al. Prediction of Stage, Grade, and Survival in Bladder Cancer Using Genome-wide Expression Data: A Validation Study , 2010, Clinical Cancer Research.
[14] H. Chiou,et al. A significantly joint effect between arsenic and occupational exposures and risk genotypes/diplotypes of CYP2E1, GSTO1 and GSTO2 on risk of urothelial carcinoma. , 2009, Toxicology and applied pharmacology.
[15] F. Montorsi,et al. Survivin as a Prognostic Marker for Urothelial Carcinoma of the Bladder: A Multicenter External Validation Study , 2009, Clinical Cancer Research.
[16] A. Chinnaiyan,et al. Development of a multiplex quantitative PCR signature to predict progression in non-muscle-invasive bladder cancer. , 2009, Cancer research.
[17] H. Chiou,et al. Association between survivin gene promoter -31 C/G polymorphism and urothelial carcinoma risk in Taiwanese population. , 2009, Urology.
[18] Y. Sekine,et al. Gene expression of survivin and its spliced isoforms associated with proliferation and aggressive phenotypes of prostate cancer. , 2008, Urology.
[19] Wun-Jae Kim,et al. Molecular biomarkers in urothelial bladder cancer , 2008, Cancer science.
[20] Anirban P. Mitra,et al. Superficial bladder cancer: an update on etiology, molecular development, classification, and natural history. , 2008, Reviews in urology.
[21] Y. Lotan,et al. Survivin expression in patients with non-muscle-invasive urothelial cell carcinoma of the bladder. , 2007, Urology.
[22] N. K. Sah,et al. Structural, functional and therapeutic biology of survivin. , 2006, Cancer letters.
[23] T. Kakizoe. Development and progression of urothelial carcinoma , 2006, Cancer science.
[24] H. Zeng,et al. Survivin nuclear labeling index: a superior biomarker in superficial urothelial carcinoma of human urinary bladder , 2006, Modern Pathology.
[25] M. Akhtar,et al. Survivin: Role in Diagnosis, Prognosis, and Treatment of Bladder Cancer , 2006, Advances in anatomic pathology.
[26] K. Miller,et al. Quantitative analysis of survivin mRNA expression in urine and tumor tissue of bladder cancer patients and its potential relevance for disease detection and prognosis , 2005, International journal of cancer.
[27] J. Wei,et al. Survivin protein expression positively correlated with proliferative activity of cancer cells in bladder cancer. , 2005, Indian journal of medical sciences.
[28] C. Kwak,et al. Expression of survivin, a novel inhibitor of apoptosis, in superficial transitional cell carcinoma of the bladder. , 2004, The Journal of urology.
[29] Yong Xu,et al. A mutation found in the promoter region of the human survivin gene is correlated to overexpression of survivin in cancer cells. , 2004, DNA and cell biology.
[30] M. Mesri,et al. Therapeutic targeting of the survivin pathway in cancer: initiation of mitochondrial apoptosis and suppression of tumor-associated angiogenesis. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[31] S. Chiou,et al. Survivin - an anti-apoptosis protein: its biological roles and implications for cancer and beyond. , 2003, Medical science monitor : international medical journal of experimental and clinical research.
[32] D. Altieri,et al. Survivin in apoptosis control and cell cycle regulation in cancer. , 2003, Progress in cell cycle research.
[33] G. Salvesen,et al. Apoptosis: IAP proteins: blocking the road to death's door , 2002, Nature Reviews Molecular Cell Biology.
[34] D. Altieri,et al. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma , 1997, Nature Medicine.
[35] H. Tung,et al. Progress in Cell Cycle Research , 1999, Progress in Cell Cycle Research.